Filter
5434
Filtered Results: 5434
Text search:
medicine
product
Featured
Recommendations
490
New Publications
1404
Language
Document type
No document type
2887
Studies & Reports
978
Guidelines
772
Manuals
297
Strategic & Response Plan
233
Fact sheets
93
Training Material
91
Situation Updates
45
Resource Platforms
15
Brochures
8
Infographics
8
Online Courses
5
App
1
Videos
1
Countries / Regions
Global
221
India
219
Kenya
159
Latin America and the Carribbean
118
Ethiopia
115
South Africa
106
Nigeria
100
Uganda
94
Nepal
90
Western and Central Europe
88
Sierra Leone
87
Liberia
78
Malawi
78
Tanzania
77
Africa
77
Zambia
67
Bangladesh
66
Myanmar / Burma
65
Ghana
62
Rwanda
57
Paraguay
57
Venezuela
56
Ukraine
46
Philippines
44
Syria
43
Zimbabwe
42
South–East Asia Region
40
Namibia
39
Colombia
38
Congo, Democratic Republic of
35
Eastern Europe
35
Argentina
31
Lesotho
31
Haiti
28
Bolivia
28
West and Central Africa
28
Guinea
26
East and Southern Africa
26
Burkina Faso
25
Cambodia
25
Mozambique
25
Senegal
24
Asia
24
Peru
23
Brazil
22
Indonesia
21
Chile
21
Middle East and North Africa
21
Cameroon
19
South Sudan
19
Ecuador
18
Eswatini/ Swaziland
17
Botswana
17
Yemen
17
Germany
15
Benin
15
Pakistan
14
USA
13
Sudan
13
Madagascar
12
Eastern Europe and Central Asia
12
Afghanistan
11
Thailand
11
El Salvador
11
Russia
11
Moldova
11
Vietnam
11
Spain
11
Mali
9
Jordan
9
Somalia
8
Lebanon
8
China
8
Iraq
7
Central African Republic
7
Western Pacific Region
7
Albania
7
Georgia
7
North Macedonia
6
Tajikistan
6
Côte d’Ivoire / Ivory Coast
5
Papua New Guinea
5
Mexico
5
Sri Lanka
5
Poland
5
Southern Africa
5
Laos
5
Iran
5
Kyrgyzstan
5
North America
5
United Kingdom
5
Hungary
4
Honduras
4
Guatemala
4
Timor Leste/ East Timor
4
Uruguay
4
Saudi Arabia
3
Niger
3
Turkey
3
Gambia
3
Dominican Republic
3
Libya
3
Angola
3
Nicaragua
3
Fiji
3
Romania
3
Kazakhstan
3
Jamaica
3
Japan
3
Mauritius
3
Morocco
2
Togo
2
Egypt
2
Chad
2
Malaysia
2
Burundi
2
Other region
2
Bhutan
2
Palestine
2
Italy
2
Mongolia
2
Qatar
2
Bulgaria
2
Estonia
2
Turkmenistan
2
France
2
Portugal
2
Belarus
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Serbia
1
Cuba
1
Greece
1
Djibouti
1
Congo-Brazzaville
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Australia
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
Norway
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2082
Clinical Guidelines
481
Public Health
336
Women & Child Health
248
Key Resources
190
Capacity Building
86
Pharmacy & Technologies
78
Annual Report MEDBOX
2
Toolboxes
COVID-19
427
Mental Health
407
TB
349
HIV
340
AMR
295
Planetary Health
200
Pharmacy
197
NTDs
158
Rapid Response
147
Disability
137
Caregiver
132
Ebola
116
Conflict
114
NCDs
114
Global Health Education
88
Refugee
62
Natural Hazards
54
Health Financing Toolbox
49
Specific Hazards
37
Zika
27
Cholera
18
Social Ethics
17
Polio
12
Health Financing
2
Typhoon
1
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and di...
- The Role of Plant Nutrition in Supporting Food Security
- Micronutrient Malnutrition: Causes, Prevalence, Consequences and Interventions
- Fertilizer Application and Nutraceutical Content in
Health-Functional Foods
- Plant Nutrition and Health Risks Associated with Plant Diseases
- Human Heal...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO Guidelines for malaria supersedes 2 previous WHO publications: the Guidelines for the treatment of mala...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
First Edition~ This self advocacy toolkit for persons with mental, neurological and substance abuse disorders, developed by Basic Needs and CBM, is the end product of an action research intervention that tracked and documented processes for Self Advocacy in low resourced communities of Uganda. Th...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations in the procurement of rapid tests.
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
This module should always be used together with the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-specialized Health
Settings (WHO, 2010), which outlines relevant general
principles of care and management of a range of other
mental, neurological and substa...
At least half of the world’s population does not have full coverage of essential health services. Health expenses push more than 100 million people into extreme poverty each and every year, forcing them into terrible choices that no one should ever have to make: Buy medicine or food? Education or ...
Int J Health Policy Manag 2017, 6(10), 587–600
Low-income countries face many contextual challenges to manage healthcare technologies effectively, as the majority are imported and resources are constrained to a greater extent. Previous healthcare technology management (HTM) policies in Benin ha...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-health sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiop...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and ...
